Congenital heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Pregnant women with gestational period >=16 weeks and undergoing routine screening for major malformations; (2) Pregnant women themselves have no acute complications that endanger the health and safety of pregnant women and fetuses, and can normally complete fetal echocardiography; (3) Sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnancy < 16 weeks, conventional ultrasound examination is difficult to see the fetal physiological structure; (2) Pregnant women complicated with acute complications may endanger the health and safety of pregnant women or fetuses at any time, and can not normally complete fetal echocardiography; (3) Subjects who could not obtain informed consent or were unwilling to provide diagnosis and treatment related data for further analysis and research according to the research requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prenatal screening rate of congenital heart disease; | — |
Countries
China
Contacts
Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine